Pacertool Establishes World-Class Scientific Advisory Board The Scientific Advisory Board Will Develop the Company Clinical…
Pacertool is solving a 20 year old problem to understand how to effectively measure the underlying mechanisms for the development of dyssynchronus heart failure. The measurement can be used as a biomarker with the ability to improve the outcome in heart failure patients. To do so, Pacertool aims to be first to market in the US and Europe with a proprietary medical device to address this unmet medical need.
Currently, 30-40% of the heart failure patients needing resynchronization therapy have limited effect of a biventricular pacemaker (CRT) implantation and around 10% of the patients are fearing worse after the implant. This affects around 40,000 patients per year and constitutes an estimated annual burden of more than USD 1B to the healthcare systems in the US and Europe. Promoting value-based healthcare, Pacertool has the potential to reduce these costs and at the same time increase the market and effectiveness of the implanted pacemakers.
Pacertool will over the next years develop the complete Pacertool system and will enter into clinical and regulatory processes to validate the technology. The company targets the US market with a staged regulatory strategy utilizing already approved devices before establishing clinical data for unique indications for use.
The company was founded by Dr. Hans Henrik Odland in 2019 and has completed the first proof-of-principle clinical trial in 45 heart failure patients. Pacertool has established a dedicated team of medical device professionals in Oslo, Norway. The team has a deep understanding of R&D processes for SW, hardware, and advanced intracardiac electrophysiology catheters.
Pacertool is here to deliver the right treatment to the right heart failure patients at the right time.
We will address the “Why?” question by focusing on three main objectives:
- We will be first to market with technologies that improve the outcomes for heart failure patients with dyssynchronous heart failure and reduced ejection fraction (HFrEF); and
- We will improve the survival chances the quality of life for HFrEF patients by optimizing the pacing approaches selected for these patients; and finally
- We will improve the workflow for the implanting physician by offering an operator agnostic, easy-to-use diagnostic tool that optimizes the pacemaker implantation.
At the core of the company lies our values which are:
Iterate from Plan A to a Plan that Works
Pacertool supports a learning environment where you are allowed to take risks, learn from your mistakes and succeed. We do accept that we can start with an initial plan and learn on our way thereby iterating to a plan that works. This is part of a lean development philosophy described well in the book “Running Lean” by Ash Maurya.
We are Here Because of an Opportunity
Celebrating success means looking back at achievements and this could lead to losing sight of the vision and goals. We therefor celebrate opportunities, looking forward keeping the vision in sight! What’s the next task? We celebrate opportunities that can bring us closer to the goal! A new task is an opportunity that brings us towards our goals and visions.
Our Company is Built on Trust
At Pacertool we believe that great achievements are founded on ethical behavior, ability to compromise, transparency, and long-term integrity. These values are not only promoted within the company’s culture but are also reflected in our cooperation with external stakeholders.
“Vi Spiller Hverandre Gode!”
The best translation of this Norwegian expression is “I pass the puck so that you can score”. In other words: Pacertool promotes a collaborative work environment where the exchange of information and ideas are critical to the company.
A Strong Sense of Community
Pacertool is creating a community where experts are encouraged to freely exchange ideas, continuously learn from one another and cooperate across disciplines, where everyone is treated fairly and with respect.
“Push, Push, Push!” A Strong Sense of Belonging to a Team that Supports You Moving Forward
Be the one in the team that enables a push forward! Be the one in the team to push forward towards the goal! Help team members move forward, explain, guide, inform, and motivate! Strengthen the engine! Point to any mistake, fault, or pushback that could prevent a push! Get out of your comfort zone!
Daglig leder / CEO
Jon H. Hoem
Jon joined Pacertool in March 2022 with more than 30 years’ Class IIb/III medical device experience in cardiac surgery and interventional cardiology filling various positions in product development, sales&marketing, and management.
He holds a master’s degree in microelectronics and organizational development from the Norwegian University of Science and Technology (NTH, now NTNU).
Jon’s first industrial challenge was to develop the first annular array multiplane transesophageal echocardiography (MPTEE) probes for adult and pediatric 3D ultrasound imaging at Vingmed Sound in the early 90’s. In 1994, Jon joined Medistim and launched their products for quality assurance of coronary bypass procedures (CABG/OPCAB) in Europe and Japan. After securing the FDA 510(k) clearance for these devices, he moved to Minneapolis (MN, USA) in 2000 and built the initial Medistim US commercial effort in a joint-venture with the cardiac surgery division of Medtronic. Medistim completed a successful IPO at the Oslo Stock Exchange in 2004.
After joining AtriCure in 2005, he moved back to Europe to restructure AtriCure’s European sales & marketing activities. During this effort, he initiated AtriCure’s European surgical training program in Barcelona, Spain, which since then has trained several hundred European cardiac surgeons in open and closed chest atrial fibrillation surgery. He also supported the first-in-patient clinical trial of the AtriClip, the first surgical left atrial appendage (LAA) closure device, at the University Hospital of Zürich, Switzerland.
Over the years since 2008, Jon headed and co-founded two early-stage interventional cardiology companies (Miracor Medical SA and CorFlow Therapeutics AG). These catheter-based technologies attempt to solve one of the most challenging problems in interventional cardiology: the diagnosis and improvement of the coronary microcirculation after a coronary stent procedure in acute heart attack patients (STEMI). Jon contributed to bringing these Class III technologies from the idea stage to clinical trials and regulatory approvals including the FDA Breakthrough Device Designation (BDD) for the CorFlow technology. His last responsibility was as Senior Business Solution Manager at Zühlke Engineering, a Swiss contract developer of medical and pharma solutions including connected health and artificial intelligence products.
Jon is the inventor and co-inventor of 14 patents and the author of multiple scientific publications focussing on the coronary microcirculation. He is the founder of Cardiac Impact GmbH.
In his spare time, Jon enjoys the outdoors with his wife Caroline and loves yoga and cooking curries.
His motto is: “Quality • Persistence • Continuous Innovation”
Founder, President and Chief Medical Officer (CMO)
Dr. Hans Henrik Odland
Hans Henrik is the Founder and past CEO of Pacertool. He has more than 25 years of experience as a Medical Doctor, starting as a Pediatrician and moving forward as a Pediatric Cardiologist and Electrophysiologist, working with both children and adults.
He completed a PhD in cardiac function assessment with novel non-invasive techniques and moved forward with his research applying novel ideas into the field of Cardiac Resynchronization Therapy in both children and adults, with CRT in adults becoming the major research interest and field of work. He is currently also holding a staff position as a Cardiac Electrophysiologist at Oslo University Hospital doing ablation procedures in children and adults with congenital heart disease and implantations of ICD/CRTs.
– 31 Journalpapers listed on Pubmed
– 3 granted patents
Research funding through Eureka Eurostars, Norwegian Research Council, Norwegian South East Health Authorities, Innovation Norway, Oslo Municipal Research Funds.
– Invited Speaker at HRS/EHRA/APHRS/AEPC on multiple occasions.
– Lecturer/Consultant Abbott, Medtronic.
Co-Founder and Chief Operating Officer (COO)
Mohammad has been with Pacertool since its establishment with more than 7 years of experience in Medical Technology, Research in Computational Physiology, and Biomedical Engineering. He holds a master’s degree in physics and Engineering in Medicine from University College London and has recently submitted his Ph.D. thesis on CRT optimization to the Faculty of Medicine at Oslo University. At Pacertool, he is responsible for the implementation of Plan A of the company and the Quality Management System.
Mohammad was born in Iraq and grew up in Norway. He moved to London at the age of twenty to study Biomedical Engineering and medical physics and proceeded to work in the fast-upscale environment of NHS, assuring optimum medical device support throughout Lister Hospital.
Passionate about MedTech, the move to research was a natural fit for Mohammad to pursue his full potential as an engineer. He moved back to Oslo in 2016 and worked as a full-time researcher in the Intervention Centre, a thrilling department in Oslo University Hospital where innovative technologies are developed, optimized and utilized. This role provided him with the necessary means to achieve a Ph.D. degree in Medical Technology.
His interest in cardiology, manifested in both his bachelor’s and master’s projects led him to focus his Ph.D. research on cardiac rhythm management devices. His Ph.D. project was part of a multidisciplinary consortium funded by the European Commission as an Innovative Training Network aiming at harvesting multi-sectorial MedTech competence in Europe. Along with the transferrable skills he gained, he collaborated with peers in multiple disciplines, including Electrophysiology, Computational Modeling, Medical Industry, and Data Science, and published multiple papers in various respected journals. He has recently completed and submitted his thesis titled “Optimal Pacing Sites in Cardiac Resynchronization Therapy”, which he expects to defend in the Autumn of 2022.
His six-month secondment with Microport CRM allowed him to be part of the development of a cutting-edge left-ventricular pacing lead enabling access to more pacing locations than any other lead technology. His secondment with Simula Research Laboratory qualified him to utilize detailed cardiac computational models to provide insight into the complex CRT outcome. Mohammad worked with Dr. Hans Henrik on multiple research projects, including a vision of creating a practical CRT implantation guidance system able to optimize CRT outcomes. That vision become a cause when Pacertool AS was established, a cause to provide the right treatment to the right heart failure patient at the right time.
Mohammad was responsible for creating and implementing the quality management system in the company, which is now ISO 13485 certified. As the Chief Operations Officer, he is involved in all ventures of the company with key responsibilities including overall planning, hiring, and supplier management. He is also the Project Manager of catheter development.
In his free time, Mohammad loves spending time with his son and traveling with his wife. He enjoys playing football with his friends on the local football team Wam-Kam and likes to play any sport that involves balls, especially volleyball, and squash.
His motto is: “Say no to the good, so you can say yes to the best.”
Co-Founder and Chief Technology Officer (CTO)
Per Magne Florvaag
Per Magne holds a master’s degree in applied mathematics with a specialization in machine learning for medical image analysis from the University of Oslo and over 10 years of software development experience. Per Magne started working with Pacertool in 2018 while it was still a research project through the company Simula Research Laboratory.
He also has experience as a consultant working on the use of AI for automating well-planning processes for large energy companies, providing technical due diligence services to European investment companies in deep- and medical technology, and as a project manager at Simula developing mobile applications deploying to over a million users.
Project and Usability Manager
Vegard joined Pacertool as Chief Hardware Engineer as of February 1st 2022. He has more than 10 years of experience from the medical device business in various positions from being a clinical support specialist to Territory Manager. He holds a Master of Science degree in Computational Physics from the University of Oslo.
Vegard started his career as Field Technical Engineer at St. Jude Medical in 2010. He quickly became an expert within the field of electrophysiology and contributed to St. Jude Medical’s growth in Norway by providing technical and clinical support during 3D-mapping EP procedures. He continued his development by becoming a product specialist also on pacemakers, ICDs and CRTs, which earned him the title of Sr. Field Technical Engineer by 2014.
In 2016 he assumed sales responsibility for the Norwegian EP business, a position he carried over to Abbott Medical after the acquisition in 2017. During his time as Territory Manager he continued to grow the business by developing a team of Field Technical Engineers as well as delivering healthy revenue growth every year.
Vegard’s desire not just to be an expert user and to sell advanced medical technology, but also to develop it, made him resign from his position at Abbott Medical in 2021 to join Pacertool.
In his spare time, he enjoys playing the guitar and to exercise.
Chief SW Engineer
Dr. Łukasz Paszkowski
Łukasz achieved his PhD in Differential Equations in 2014 from the University of Wrocław. His interest in programming from an early age, coupled with his advanced math education led him to build a solid career as a scientific programmer. Łukasz has built the Pacertool Software, our main product, from scratch and is naturally leading the software development in the company.
Senior SW Engineer and Data Scientist
Dr. Maciej Marciniak
Maciej joined Pacertool in August 2021 with 5 years of experience in cardiac morphology analysis, scientific research on cardiac imaging, biomedical engineering, and data science.
He holds a master’s degree in Informatics from the University of Oslo and a PhD degree from King’s College London, with his thesis titled ‘Computational analysis of human cardiac anatomy and its interaction with the heart’s function’.
Maciej’s scientific journey began in Simula Research Laboratory in Oslo, in 2016, with the use of statistical shape atlases on the heart models derived from cardiac magnetic resonance images. The analysis resulted in a few publications presented in the international conferences, as well as successful defence of his master thesis in 2017. In 2018, Maciej became an MSCA fellow affiliated with King’s College London, where he collaborated closely with both clinical and industrial facilities around Europe and made significant contributions in the form of scientific publications, publicly available software applications, and computational models.
During a secondment at Hospital-Clinic in Barcelona, in 2018, working closely with the clinical researchers Maciej developed an application for data extraction, processing, and visualization as an API of EchoPAC (GE Healthcare) software. This work was used in multiple journal and conference publications regarding the basal septal hypertrophy in patients with hypertension and was awarded the best-moderated poster presentation during the prestigious European Society of Cardiology conference in 2019.
In 2019 Maciej moved back to Oslo to work as a biomedical research consultant at GE Healthcare. Along with the PhD fellows from both London and Oslo, he developed an artificial data set of over 1000 four-chamber human hearts. The models were built with high accuracy and are openly available, currently used by about 100 different cardiac research groups for detailed electrophysiological and mechanical simulations. As the consultant for GE, Maciej helped to employ the models in a novel application for automatic segmentation of echocardiography images, with numerous applications within the company’s devices.
In the meantime, since 2020, Maciej established a collaboration with the researchers from Oxford University to study the impact of the preterm birth on the heart’s anatomy and function. Moreover, along with the clinical team from Erasmus Medical Centre in Rotterdam, he studied large sets of pediatric cardiac data to describe the connection between childhood obesity and the heart’s morphology. The results from all the aforementioned research projects have been published in high-impact cardiological journals.
Maciej also actively pursued public engagement activities to inform the public about the state of modern cardiological research. Through a collaboration with the artistic studio Cellule, he presented the Big Heart Data installation (50 3D printed heart models with a digital interface of anatomical variability), at Science Gallery London, and an extended version of it (with 3D printers and different materials) at New Scientist Live! expo in London, in 2019, reaching out to about 150 000 visitors.
Maciej’s hobbies include travelling with his Fiancée Neringa, squash, ice- and roller skating, and playing board games. His ambition has always been to make the applications and tools that he is developing useful for both patients and the research community.
Elin joined Pacertool in August 2022, shortly after her graduation. She holds a bachelor’s degree in Mathematics with Informatics and a master’s degree in Bioinformatics, both from the University of Oslo. As part of her bachelor’s degree, she studied one semester abroad at the University of Minnesota.
Solving health issues using data science has been her career goal since early in her studies, making Pacertool the perfect match.
Despite being a recent graduate, Elin has experience as a research assistant at the Norwegian Defense Research Establishment. There she worked on methods for filtering sensor data and curve fitting.
Outside of work, Elin enjoys hiking, bouldering and playing the flute. She is currently playing in Sagene janitsjarkorps and has previously played in His Majesty the King’s Guard band as part of her compulsory service.
Mathias joined Pacertool in September 2022 as a software engineer. He completed his Master of Science degree in Computational Physics at the University of Oslo in the spring of 2019, where he worked on simulating the strong nuclear force. After completing his thesis, he started working as a scientific software engineer within the field of Earth Observation, gaining valuable experience on solving large-scale numerical problems and working on complex code bases.
During his thesis at the University of Oslo at Computational Physics, Mathias developed a strong passion for programming and large-scale numerical simulations. This led him to begin at a small Norwegian company that worked within the Norwegian space industry, where he – among other projects – helped develop the instrument data simulator for the upcoming Sentinel-4 ESA satellite. He also assisted in creating cloud-free mosaics and measuring the glacier velocity on Greenland from satellite imagery.
In his spare time Mathias enjoys climbing, programming and reading sci-fi books.
SAB (Scientific Advisory Board)
The Pacertool Scientific Advisory Board (SAB) is comprised of leading clinicians with decades of experience in developing and implementing clinical trials for heart failure patients in need of pacing. The SAB will make important contributions to Pacertool’s clinical trial strategy, ensure alignment with current trends in cardiac pacing for heart failure patients and provide input to the Pacertool innovation pipeline.
Prof. Michael Gold, MD, PhD
Medical Univ. of South Carolina, Charleston, SC
Principal investigator of landmark CRT trials FDA advisor, leading consultant for medical device corporates
Dr. Gold is the Michael E. Assey Professor of Medicine and Distinguished University Professor at the Medical University of South Carolina. He has authored more than 300 articles in peer-reviewed journals, in addition to over 30 book chapters.
He has been the PI or served on the Steering Committee of more than 15 multi-national clinical trials. Dr. Gold sits on the editorial board of several peer-reviewed journals, including American Journal of Cardiology, JACC, JACC EP, Circulation AE, Heart Rhythm 02 and the Journal of Cardiac Electrophysiology. He is a Section Editor for Heart Rhythm and editor in chief of Current Cardiovascular Risk Reports. He is a former President of the Heart Rhythm Society and the Association of Professors of Cardiology.
Prof. Christophe Leclercq, MD, PhD
CHU Pontchaillou, Rennes, France
President European Heart Rhythm Association, Vice President European Society of Cardiology, CRT guidelines writing committee.
Prof. Leclercq is practicing at the Centre Hospitalier Universitaire of Rennes (France) and is chief of the cardiology department. His main areas of interest include device therapy for arrhythmias and heart failure. He is a board member of the European Heart Rhythm Association and the European Society of Cardiology.
He had published more than 200 manuscripts related to cardiac resynchronization therapy.
Prof. Cecilia Linde, MD, PhD
Karolinska Univ. Hospital, Stockholm, Sweden
Vice President of the Board European Society of Cardiology, member of guidelines writing committees.
Prof. Linde is a professor and consultant in cardiology at the Karolinska University Hospital in Stockholm, Sweden. Her research currently focuses on devices and their implementation and epidemiology in heart failure.
Prof. Linde is the author of more than 250 papers, reviews, and editorials in a wide variety of fields including CRT, sex and arrhythmia, hemodynamic monitoring and heart failure epidemiology and she serves on the editorial board of several journals. She is editor for the European heart Journal. She has been a board member of the European Heart Rhythm Association (EHRA) and has served on many guidelines writing committees of EHRA and the Heart Failure Association.” She was Vice President of the ESC 2018-2020 and is now the Secretary Treasurer of the ESC.
Dr. Pugazhendhi Vijayaraman, MD
Geisinger Heart, Wilkes-Barre, PA
Principal investigator of landmark CRT trials, special interest novel physiological pacing
Dr. Vijayaraman specializes in cardiac electrophysiology, cardiac ablations (AFib, VT), cardiac device implantation, His-bundle pacing and Watchman™. Dr. Vijayaraman obtained his medical degree from Madurai Medical College.
He completed his residency at Jacobi Medical Center and his fellowships in cardiovascular diseases and clinical cardiac electrophysiology at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center. He is board certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease, and clinical cardiac electrophysiology.
Governance (Board of Directors)
Pacertool’s Board of Directors consists of healthcare professionals and investors with a solid track record in managing and overseeing successful early stage growth companies:
Chairman of the Board
Tom is a life science industry professional various holding board positions and other engagements. He has over 35 years of experience in the health industry, including global responsibilities at Roche in Switzerland and as CEO of Roche Norway, Partner at the venture capital fund NeoMed and Chairman of the pharmaceutical industry association (LMI).
For the past 15 years, the main focus has been on start-up companies in Norway and Sweden. He combines his board positions and consulting work with a part-time engagement at Oslo Metropolitan University working with innovation infrastructure.
Tom Pike was the chairman of Vaccibody (now NyKode Therapeutics) for 11 years and currently also serves on the boards of Inven2, Vingmed Holding, Vectron Biosolutions, and Digital Life Norway. He holds a B.Sc. Honors in pharmacology and has participated in a number of educational programs in business & administration, sales & marketing, and finance.
Member of the Board
Dr. Hans Henrik Odland
Hans Henrik is the Founder and past CEO of Pacertool. He has more than 25 years of experience as a Medical Doctor, starting as a pediatrician and moving forward as a Pediatric Cardiologist and Electrophysiologist, working with both children and adults.
He completed a Ph.D. in cardiac function assessment with novel non-invasive techniques and moved forward with his research applying novel ideas to the field of Cardiac Resynchronization Therapy in both children and adults, with CRT in adults becoming the major research interest and field of work.
He is currently also holding a staff position as a Cardiac Electrophysiologist at Oslo University Hospital doing ablation procedures in children and adults with congenital heart disease and implantations of ICD/CRTs.
Member of the Board,
CEO and Founding Partner, p53
Dr. Susanne Stuffers
Susanne holds an M.D. degree from the Erasmus University Rotterdam, Netherlands, and a Ph.D. degree in cancer biomedicine from the Norwegian Radiumhospital.
She gained broad experience in healthcare and life sciences, covering the sector from several angles. Susanne was a management consultant in health care (public and private) and life sciences at EY, served in medical and commercial roles in the pharmaceutical industry (Novartis), and has clinical practice as a resident in oncology. She worked with Arctic Securities as an equity analyst covering the healthcare sector, before joining forces with T.D. Veen to co-found and lead p53.
Susanne has supported life science companies in different phases of development, from start-up to late clinical stage, and has experience from financial markets including private placements and IPOs.
Member of the Board, Partner,
Investment Advisor Sarsia Seed
Dr. Øivind Enger
Øivind has over 13 years of research experience in molecular biology and fish disease, and 5 years in commercialising research based projects in biology, aqua culture, medicine and biotechnology. He has several years of managerial and board experience from position with Sarsia Innovation AS.
Non-Executive Board Member
Mona K. Berg
Mona joined Pacertool as a Board Member as of 24th Jan. 2022. She has more than 30 years of experience from the Medical Technical business in various positions from being a Sales Representative to General Manager – in Norway, Nordics and Europe.
She holds a Bachelor in Nursing from Oslo University Hospital and a Bachelor in Marketing, Business and Management from The Norwegian School of Marketing and Business Studies/BI.
Mona started her career as a Sales Representative with two national distributors: Gallus Plesner/KEBO and Cardiac. In Cardiac, she was hired to build the SciMed Life System product portfolio business in invasive cardiology from scratch. Mona helped and supported the university hospitals to develop this therapy. She was also involved in the cardiothoracic products, amongst other the Carbomedics heart valves and held the position as Manager the last two years of her career with Cardiac.
In 1995, SciMed Life Systems was acquired by Boston Scientific Cooperation (BSC) and Mona became SM, responsible for the overall business in Norway and Denmark. She created partnerships and collaboration in these two countries resulting in an increased PCI footprint vs CABG. BSC created a Nordic organization with a strong focus on therapy and product development in close collaboration with the invasive cardiologist.
In 2004 Mona accepted an offer from St. Jude Medical (SJM) to start its business in Norway from scratch as an SM, and later as a CM. She was responsible for CRM (pacemakers/ICDs) and invasive cardiology products. In parallel, Mona built a strong team who shared the winning spirit and ambitious targets. The rest of SJMs products within EP/AF, Cardiac Surgery, and Structural Heart were launched as well and SJM became the market leader in several of the therapy areas.
In 2013 Mona was appointed Nordic GM for Neuromodulation (NM) in parallel being CM Norway. She restructured the Nordic NM team to be more efficient with a true Nordic perspective and SJM became the market leader in all countries.
In 2017 St. Jude Medical was acquired by Abbott. Mona became the GM for NM in Northern Europe (Benelux, Nordic, and UK/IRE) and also Poland, Russia, Czech, Hungary, Greece, and Israel in the last two years. She was responsible for restructuring the organization in each country, creating a regional team, building a KOL network, developing processes to secure alignment across the region, defining and creating a winning culture, and meeting the financial targets and commitments.
Mona resigned from this position in Q2, 2021 to focus on some private projects, identify business opportunities for market growth and penetration in MedTech, and be open for project collaboration with other senior executives from MedTech/pharma and board engagements.
In her spare time, she enjoys skiing, hiking, traveling, and reading – on her own or with her husband Tom and 3 adult children.
Her motto is:
«Winning Spirit – Walk the talk – Persistence – Implementation/execution»
Member of the Board,
Portfolio Manager at Rasmussengruppen AS
Børre AB Grønningsæter
Børre started work as a stockbroker in 1994 for Saga Securities AS in Oslo (now Danske Securities) where he became partner in 1995. In 1998 he joined RASMUSSENGRUPPEN AS where he holds the position as Portfolio Manager. He is also CEO for the two subsidiaries PORTIA AS and CRESSIDA AS, fully owned by RASMUSSENGRUPPEN AS.
Børre holds a Bachelor degree from NHH (Norwegian school of Economics and Business Administration) and a degree in Building and Construction from Gothenburg Technical Institute.
Pacertool is dedicated to providing uncompromised quality products and effective solutions to health care professionals and patients by always complying with applicable national and international regulatory requirements.
We strive for continuous improvement and believe that listening to customer needs and meeting market needs are key to optimal product quality.
Pacertool follows an ISO13485:2016 compliant quality management system, certified by BSI, our Notified Body. Please refer to the ISO certificate below.
Pacertool has recently closed a seed financing round supported by a prominent Norwegian investor consortium: TD Veen/p53, Sarsia Seed and the Rasmussen Group. The company has also received public funding through the Norwegian Research Council, Innovation Norway and the European Union.
Our investors have a long-term perspective of building a successful medical device company and has a track record of supporting other successful Norwegian biotech and medical device companies such as Nykode (Vaccibody) and BerGenBio. In the words of TD Veen/p53: “We seek to contribute to the development and commercialization of groundbreaking ideas that will increase accessibility to cutting-edge treatments and innovative solutions with positive effect on quality of life and well-being”.
Pacertool has also secured non-dilutive funding from the Research Council of Norway, Innovation Norway and through the Eureka Eurostars program.
We are welcoming new investors who share the Pacertool vision of precision treatment of heart failure patients.
For further information please contact our CEO, Jon H. Hoem, at firstname.lastname@example.org or call at +47 97 30 30 09.
Innovation project for the industrial sector We are pleased to announce that Pacertool has been…